20
Participants
Start Date
May 4, 2015
Primary Completion Date
August 12, 2015
Study Completion Date
August 13, 2015
BI 409306
high dose, single dose, oral administration
BI 409306
low dose, single dose, oral administration
Placebo
single dose, oral administration
1289.28.1 Boehringer Ingelheim Investigational Site, Biberach
Lead Sponsor
Boehringer Ingelheim
INDUSTRY